Viewing Study NCT00562250


Ignite Creation Date: 2025-12-24 @ 5:04 PM
Ignite Modification Date: 2026-01-01 @ 2:02 PM
Study NCT ID: NCT00562250
Status: COMPLETED
Last Update Posted: 2016-10-17
First Post: 2007-11-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module